PV Bulletin

Pharmatech MK-677 Capsules: Undisclosed Anabolic Steroid Found

TGA safety alert: Pharmatech-branded MK-677 capsules found to contain undeclared metandienone, an anabolic steroid with serious health risks.

Primary source: https://www.tga.gov.au/news/safety-alerts/pharmatech-branded-mk-677-capsules-containing-ibutamoren-may-pose-serious-risk-your-health

PV Impact Brief

Urgency: HighConfidence: high

What changed

TGA issued a safety alert on 4 June 2026 after lab testing found undeclared metandienone in Pharmatech MK-677 capsules.

Why it matters

Metandienone is an anabolic steroid with known serious adverse effects; its undisclosed presence poses significant health risks to consumers.

Action needed

Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Regulatory action details

Action type
Safety Alert
Publication date
2026-06-04
Safety issue
Laboratory testing of 'Pharmatech' branded MK-677 capsules (containing ibutamoren) found that the capsules contained undeclared metandienone (an anabolic steroid). Metandienone can cause serious health risks including liver damage and cardiovascular issues.

Affected products

  • MK-677 capsules
    Pharmatech

PV internal implications

Stop using the capsules immediately. Consult a medical professional if you have concerns. Dispose of any remaining product.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 4, 2026

Full briefing

Practical implication

Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

Laboratory testing of Pharmatech MK-677 capsules (containing ibutamoren) revealed undeclared metandienone, an anabolic steroid that can cause liver damage and cardiovascular issues. TGA advises immediate cessation of use and disposal of remaining product.

What changed: TGA issued a safety alert on 4 June 2026 after lab testing found undeclared metandienone in Pharmatech MK-677 capsules.

Why it matters: Metandienone is an anabolic steroid with known serious adverse effects; its undisclosed presence poses significant health risks to consumers.

Practical implication: Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Safety Signals#firecrawl-agent#regulatory-extraction#Other#Therapeutic Goods Administration (TGA)#Safety Alert#Quality Defect#Contamination

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward